SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-095072
Filing Date
2024-08-12
Accepted
2024-08-12 08:04:26
Documents
12
Period of Report
2024-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K coya-20240812.htm   iXBRL 8-K 40769
2 EX-99.1 coya-ex99_1.htm EX-99.1 260239
  Complete submission text file 0000950170-24-095072.txt   436156

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT coya-20240812.xsd EX-101.SCH 26033
14 EXTRACTED XBRL INSTANCE DOCUMENT coya-20240812_htm.xml XML 4929
Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Filer) CIK: 0001835022 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41583 | Film No.: 241194792
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)